Recalls of generic Zantac believed to be contaminated by a carcinogen continue to flood in. Two other firms have declared recalls of ranitidine heartburn meds in 150 mg and 300 mg doses. The news arrived even as the degree of the drug returns increased with Mylan’s impromptu recall of three lots of nizatidine capsules last week because the API in them also held dangerous levels of NDMA.
Why Companies Recalled Heartburn Medications
Zantac Generics Recall Grows Due to Cancer Risk
Stryker Hip Implant Failures
The Stryker Tritanium Acetabular Shell, which restores the human hip socket, is built from a titanium alloy covered with a unique kind of porous foam. The foam enables bone cells to bind with it and grow, thereby increasing joint stability. However, a 2018 report in the journal Arthroplasty Today by doctors at NYU Langone Orthopedic Hospitals described five hip implant failures related to Stryker’s Tritanium cups between 2011 and 2016.
Stryker Adds More Products to Hip Implant System Recall List
Following its warning two years ago, Stryker recently updated the public about the LFIT Anatomic CoCr V40TM product line, and the news is not good. Stryker again warned orthopedic surgeons implanting the femoral heads that the risk continues to be "higher than expected" and in addition the company added eight more catalog numbers to its official recall list.
Green, Schafle & Gibbs Represents Couple in Stryker Hip Implant Suit
Green, Schafle & Gibbs represents a Pittsburgh couple who are suing Howmedica Osteonics Corporation d/b/a Stryker Orthopaedics for a defective hip implant. Attorneys Michael Schafle and Jon Acklen filed a complaint on behalf of their clients last month in US District Court alleging that Stryker’s hip implant had a design defect and failed.